Because our results indicated that systemic MIF levels are critical for resistance and induction of TipDCs during acute toxoplasmosis, we confirmed these data by administration (via i.p.) of rMIF into Mif−/− mice (0.5 μg per mouse) daily during the first 5 days after T. gondii infection. This evidence concerns the gene MIF and toxoplasmosis.